Learn About BPH Medicare Coverage Options

What BPH Is and How Medicare May Cover It

Benign prostatic hyperplasia, commonly called BPH, is a condition where the prostate gland becomes enlarged. The prostate is a walnut-sized gland that sits below the bladder in men. As men age, the prostate often grows larger, which is a normal part of aging. This growth can press on the urethra—the tube that carries urine from the bladder—and cause urinary symptoms.

According to the National Institute of Diabetes and Digestive and Kidney Diseases, about half of men in their 60s experience some BPH symptoms. By age 80, the number rises to about 90%. BPH is not cancer, and it does not increase the risk of prostate cancer. However, the symptoms can affect daily life and sleep quality.

Medicare is a federal health insurance program that covers people age 65 and older, some younger people with disabilities, and people with end-stage renal disease. Medicare has different parts that cover different types of care. Part B covers doctor visits, diagnostic tests, and certain procedures. Understanding what Medicare covers for BPH requires knowing how the program works and what services fall under each part.

Medicare coverage for BPH typically includes doctor visits to diagnose the condition, imaging tests like ultrasounds, and procedures to treat symptoms. The coverage varies depending on whether the service is considered medically necessary and meets Medicare's guidelines. This guide explains what types of BPH care may be covered, what costs you might encounter, and what options exist within the Medicare program.

Takeaway: BPH is a common, non-cancerous enlargement of the prostate that affects many men over 60. Medicare may cover various services related to BPH diagnosis and treatment through its different parts and coverage categories.

Medicare Part B Coverage for BPH Diagnosis and Doctor Visits

Medicare Part B is hospital insurance that covers outpatient services, including visits to doctors, specialists, and certain diagnostic tests. For BPH, Part B typically covers the initial evaluation and ongoing management by your primary care doctor or a urologist. When you visit a doctor for BPH symptoms, Medicare Part B generally covers 80% of the approved amount after you meet your annual deductible, which is $240 for 2024.

A doctor diagnosing BPH will typically perform a physical exam and ask about your symptoms. Part B covers this office visit. The doctor may order tests to measure how much urine remains in the bladder after urination, called a post-void residual test. This test may use ultrasound technology and is often covered by Part B. Another common diagnostic tool is urinalysis, which checks for infection or other problems, and is also generally covered.

Your doctor may also perform a digital rectal exam (DRE) to feel the size and texture of the prostate. This exam is part of the office visit and is covered. Some doctors order a prostate-specific antigen (PSA) blood test to rule out prostate cancer. Medicare Part B covers one PSA test per year for men 50 and older as a screening service, though this is separate from diagnostic testing for BPH.

If your symptoms require specialist care, Medicare Part B covers visits to a urologist. These visits are treated the same way as primary care visits regarding coverage—Medicare pays 80% of the approved amount after the deductible. Ongoing management visits, including medication adjustments and symptom monitoring, are covered by Part B as long as they are determined to be medically necessary.

Takeaway: Medicare Part B covers doctor visits and diagnostic tests for BPH, paying 80% of approved costs after meeting the annual deductible. Both primary care doctors and specialists are covered.

Imaging and Diagnostic Tests Covered by Medicare

Several imaging and diagnostic tests help doctors diagnose and monitor BPH. These tests provide information about the size of the prostate, the amount of urine remaining in the bladder, and whether urine flow is obstructed. Medicare Part B covers many of these tests when ordered by a doctor as part of BPH diagnosis and management.

Pelvic ultrasound is one of the most common tests for BPH evaluation. This painless test uses sound waves to create images of the prostate and bladder. It can measure the size of the prostate and detect how much urine remains after urination. Medicare Part B typically covers pelvic ultrasound when medically necessary. The cost to you depends on whether your doctor is a participating Medicare provider and whether you have met your annual deductible.

Urinalysis is a simple urine test that checks for infection, blood, or protein in the urine. Since urinary tract infections can cause BPH-like symptoms, this test helps rule out other problems. Medicare Part B covers urinalysis as part of diagnostic services. The test is inexpensive but is usually included in office visit charges rather than billed separately.

Uroflowmetry is a test that measures how fast urine flows and how long urination takes. The patient urinates into a special toilet that measures the flow rate. This test shows whether urinary obstruction from BPH is affecting urine flow. Medicare Part B covers uroflowmetry when it is ordered by a doctor to evaluate suspected urinary obstruction. Some urologists use this test routinely in BPH evaluation, while others use it only in specific cases.

Cystoscopy is a procedure where a thin, lighted tube is inserted into the urethra and bladder to visualize the inside of the bladder and urethra. This procedure may be performed if the diagnosis is unclear or if the doctor suspects other problems like bladder stones or cancer. Medicare Part B covers cystoscopy when medically necessary, though it is typically performed in an outpatient surgery center or hospital. You may have copayment responsibilities depending on the facility and your specific coverage.

Takeaway: Medicare Part B covers multiple diagnostic tests for BPH including ultrasound, urinalysis, uroflowmetry, and cystoscopy, though coverage depends on medical necessity and your deductible status.

Medicare Coverage for BPH Medications and Treatment Options

Several types of medications treat BPH symptoms by either relaxing the smooth muscle in the prostate and bladder neck or by shrinking the prostate itself. Medicare Part D, the prescription drug coverage part of Medicare, covers many BPH medications, though coverage varies by plan and medication.

Alpha-blockers are medications that relax smooth muscle in the prostate and bladder neck, improving urine flow and reducing symptoms. Common alpha-blockers include tamsulosin (Flomax), doxazosin (Cardura), and terazosin (Hytrin). These medications are widely available and typically inexpensive. Medicare Part D usually covers alpha-blockers, though you may need to pay a copayment, and some plans may require prior authorization before covering them.

5-alpha reductase inhibitors are medications that shrink the prostate by blocking the hormone that causes prostate growth. The two main medications in this class are finasteride (Proscar) and dutasteride (Avodart). These medications take several months to show results but can significantly reduce prostate size in men with larger prostates. Medicare Part D generally covers both of these medications, though copayments and cost-sharing apply.

Combination therapy using both an alpha-blocker and a 5-alpha reductase inhibitor is sometimes prescribed for men with moderate to severe symptoms. Medicare Part D covers both types of medications, so combination therapy is covered under most plans. The total out-of-pocket costs for combination therapy depend on your specific Part D plan's formulary and cost-sharing structure.

In addition to medications, men with BPH may benefit from behavioral changes such as limiting fluid intake before bed, reducing caffeine and alcohol consumption, and avoiding medications that worsen symptoms. These lifestyle approaches are not covered by Medicare because they are not services or products that generate claims. However, doctors often recommend these changes as a first step before starting medication.

Takeaway: Medicare Part D covers common BPH medications including alpha-blockers and 5-alpha reductase inhibitors, with coverage and costs varying by individual plan.

Medicare Coverage for Surgical and Minimally Invasive Procedures

When medications do not adequately control